Chronic left atrial volume overload abbreviates the action potential duration of the canine pulmonary vein myocardium via activation of IK channel

European Journal of Pharmacology

Volumn 597, Issue 1-3, 2008, Pages 81-85

  Nouchi, Hideaki ^a   Takahara, Akira ^a,b   Nakamura, Hideki ^a   Namekata, Iyuki ^a   Sugimoto, Takahiko ^a   Tsuneoka, Yayoi ^a   Takeda, Kiyoshi ^a   Tanaka, Toshikazu ^a   Shigenobu, Koki ^a   Sugiyama, Atsushi ^b   Tanaka, Hikaru ^a  

^a TOHO UNIVERSITY   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Membrane potential; Potassium channel; Pulmonary vein myocardium; Repolarization; Stretch

Indexed keywords

INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATRIOVENTRICULAR BLOCK; CONTROLLED STUDY; DOG; HEART ATRIUM; HEART ATRIUM ENLARGEMENT; HEART MUSCLE; HYPERVOLEMIA; LEFT ATRIAL VOLUME OVERLOAD; MEMBRANE STEADY POTENTIAL; MICROELECTRODE; NONHUMAN; PRIORITY JOURNAL; PULMONARY VEIN;

ACTION POTENTIALS; ANIMALS; ATRIAL FUNCTION, LEFT; ATRIOVENTRICULAR BLOCK; CHARYBDOTOXIN; CHRONIC DISEASE; DILATATION, PATHOLOGIC; DISEASE MODELS, ANIMAL; DOGS; HEART ATRIA; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MYOCARDIUM; PEPTIDES; POTASSIUM CHANNEL BLOCKERS; PULMONARY VEINS; TIME FACTORS;

EID: 53449090086     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.09.002     Document Type: Article

References (26)

1. Arora R., Verheule S., Scott L., Navarrete A., Katari V., Wilson E., Vaz D., and Olgin J.E. Arrhythmogenic substrate of the pulmonary veins assessed by high resolution optical mapping. Circulation 107 (2003) 1816-1821
2. Bode F., Katchman A., Woosley R.L., and Franz M.R. Gadolinium decreases stretch-induced vulnerability to atrial fibrillation. Circulation 101 (2000) 2200-2205
3. Bode F., Sachs F., and Franz M.R. Tarantula peptide inhibits atrial fibrillation. Nature 409 (2001) 35-36
4. Ehrlich J.R., Cha T.J., Zhang L., Chartier D., Melnyk P., Hohnloser S.H., and Nattel S. Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties. J. Physiol. 551 (2003) 801-813
5. Fukuda T., Yamashita T., Sagara K., Kato T., Sawada H., and Aizawa T. Development of congestive heart failure in Japanese patients with atrial fibrillation. Circ. J. 71 (2007) 308-312
6. Galvez A., Gimenez-Gallego G., Reuben J.P., Roy-Contancin L., Feigenbaum P., Kaczorowski G.J., and Garcia M.L. Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J. Biol. Chem. 265 (1990) 11083-11090
7. Gimenez-Gallego G., Navia M.A., Reuben J.P., Katz G.M., Kaczorowski G.J., and Garcia M.L. Purification, sequence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 3329-3333
8. Ca in endothelium-dependent hyperpolarizations of the guinea-pig isolated carotid artery. Br. J. Pharmacol. 144 (2005) 477-485
9. + channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol. Pharmacol. 45 (1994) 1227-1234
10. Haissaguerre M., Jais P., Shah D.C., Takahashi A., Hocini M., Quiniou G., Garrigue S., Le Mouroux A., Le Metayer P., and Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 339 (1998) 659-666
11. Kalifa J., Jalife J., Zaitsev A.V., Bagwe S., Warren M., Moreno J., Berenfeld O., and Nattel S. Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation. Circulation 108 (2003) 668-671
12. Kawakubo T., Naruse K., Matsubara T., Hotta N., and Sokabe M. Characterization of a newly found stretch-activated KCa,ATP channel in cultured chick ventricular myocytes. Am. J. Physiol. 276 (1999) H1827-H1838
13. Melnyk P., Ehrlich J.R., Pourrier M., Villeneuve L., Cha T.J., and Nattel S. Comparison of ion channel distribution and expression in cardiomyocytes of canine pulmonary veins versus left atrium. Cardiovasc. Res. 65 (2005) 104-116
14. Nattel S. Basic electrophysiology of the pulmonary vein and their role in atrial fibrillation: precipitators, perpetuators, and perplexers. J. Cardiovasc. Electrophysiol. 14 (2003) 1372-1375
15. Neuberger H.R., Schotten U., Verheule S., Eijsbouts S., Blaauw Y., van Hunnik A., and Allessie M. Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat. Circulation 111 (2005) 30-37
16. Neuberger H.R., Schotten U., Blaauw Y., Vollmann D., Eijsbouts S., van Hunnik A., and Allessie M. Chronic atrial dilation, electrical remodeling, and atrial fibrillation in the goat. J. Am. Coll. Cardiol. 47 (2006) 644-653
17. Ca) channels to the relaxation of guinea-pig aorta in response to natriuretic peptides. J. Smooth Muscle Res. 38 (2002) 117-129
18. Ravelli F., and Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation 96 (1997) 1686-1695
19. Schoonderwoerd B.A., Van Gelder I.C., Van Veldhuisen D.J., Van den Berg M.P., and Crijns H.J. Electrical and structural remodeling: role in the genesis and maintenance of atrial fibrillation. Prog. Cardiovasc. Dis. 48 (2005) 153-168
20. Sugiyama A., Ishida Y., Satoh Y., Aoki S., Hori M., Akie Y., Kobayashi Y., and Hashimoto K. Electrophysiological, anatomical and histological remodeling of the heart to AV block enhances susceptibility to arrhythmogenic effects of QT-prolonging drugs. Jpn. J. Pharmacol. 88 (2002) 341-350
21. Takahara A., Sugiyama A., Satoh Y., Iwasaki H., Nakamura Y., and Hashimoto K. Cardiovascular profile of the canine torsades de pointes arrhythmia model assessed by echocardiographic and haemodynamic methods. Basic Clin. Pharmacol. Toxicol. 101 (2007) 35-40
22. Takahara A., Nakamura H., Nouchi H., Tamura T., Tanaka T., Shimada H., Tamura M., Tsuruoka N., Takeda K., Tanaka H., Shigenobu K., Hashimoto K., and Sugiyama A. Analysis of arrhythmogenic profile of the chronic atrioventricular block dog by comparing in vitro effects of class III antiarrhythmic drug nifekalant on the ventricular action potential indices between the normal heart and atrioventricular block heart. J. Pharm. Sci. 103 (2007) 181-188
23. Thijssen V.L.J.L., Ausma J., and Borgers M. Structural remodelling during chronic atrial fibrillation: act of programmed cell survival. Cardiovasc. Res. 52 (2001) 14-24
24. Verdecchia P., Reboldi G., Gattobigio R., Bentivoglio M., Borgioni C., Angeli F., Carluccio E., Sardone M.G., and Porcellati C. Atrial fibrillation in hypertension: predictors and outcome. Hypertension 41 (2003) 218-223
25. Ca-channel activity in human cardiac fibroblasts to electrical coupling of cardiomyocytes-fibroblasts. J. Membr. Biol. 213 (2006) 175-185
26. Wang K., Takahara A., Nakamura Y., Aonuma K., Matsumoto M., and Sugiyama A. In vivo electropharmacological effects of amiodarone and candesartan on atria of chronic atrioventricular block dogs. J. Pharm. Sci. 103 (2007) 207-213